Novel uses of antibodies against ache and peptides thereof

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/40 (2006.01) G01N 33/573 (2006.01)

Patent

CA 2371675

The invention relates to antibodies recognizing acetylcholinesterase or a C- terminal peptide derived from acetylcholinesterase, useful in diagnosing central nervous system (CNS) stress, elevated glucocorticoid level, disruption of the blood-brain barrier or Alzheimer's disease. The invention also relates to methods for the diagnosis of central nervous system (CNS) stress, elevated glucocorticoid level or disruption of the blood-brain barrier in a mammal, by use of the antibodies of the invention.

L'invention concerne des anticorps reconnaissant l'acétylcholinestérase ou un peptide C-terminal dérivé de l'acétylcholinestérase, utiles dans le diagnostic du stress du système nerveux central (SNC), de niveaux élevés de glucocorticoïdes, d'un dérèglement de la barrière hémato-encéphalique ou de la maladie d'Alzheimer. L'invention concerne également des techniques de diagnostic du stress du système nerveux central (SNC), de niveaux élevés de glucocorticoïdes ou d'un dérèglement de la barrière hémato-encéphalique chez un mammifère, utilisant les anticorps de l'invention.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel uses of antibodies against ache and peptides thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel uses of antibodies against ache and peptides thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel uses of antibodies against ache and peptides thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1813082

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.